nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—CA5B—Hydrochlorothiazide—nephrolithiasis	0.14	0.191	CbGbCtD
Furosemide—CA9—Hydrochlorothiazide—nephrolithiasis	0.12	0.164	CbGbCtD
Furosemide—CA12—Hydrochlorothiazide—nephrolithiasis	0.12	0.164	CbGbCtD
Furosemide—CA1—Hydrochlorothiazide—nephrolithiasis	0.112	0.153	CbGbCtD
Furosemide—CA4—Hydrochlorothiazide—nephrolithiasis	0.105	0.144	CbGbCtD
Furosemide—CA2—Hydrochlorothiazide—nephrolithiasis	0.0968	0.133	CbGbCtD
Furosemide—SLC22A6—Hydrochlorothiazide—nephrolithiasis	0.0373	0.051	CbGbCtD
Furosemide—SLC12A1—loop of Henle—nephrolithiasis	0.0194	0.239	CbGeAlD
Furosemide—SLC12A1—collecting duct of renal tubule—nephrolithiasis	0.011	0.136	CbGeAlD
Furosemide—Xanthopsia—Hydrochlorothiazide—nephrolithiasis	0.00714	0.0877	CcSEcCtD
Furosemide—Angiitis necrotising—Hydrochlorothiazide—nephrolithiasis	0.00714	0.0877	CcSEcCtD
Furosemide—Vasculitis necrotising—Hydrochlorothiazide—nephrolithiasis	0.00622	0.0764	CcSEcCtD
Furosemide—CA2—collecting duct of renal tubule—nephrolithiasis	0.0049	0.0605	CbGeAlD
Furosemide—SLC12A1—nephron—nephrolithiasis	0.00489	0.0604	CbGeAlD
Furosemide—SLC12A1—urine—nephrolithiasis	0.00393	0.0485	CbGeAlD
Furosemide—Gastric irritation—Hydrochlorothiazide—nephrolithiasis	0.00336	0.0413	CcSEcCtD
Furosemide—SLC22A8—nephron—nephrolithiasis	0.00284	0.0351	CbGeAlD
Furosemide—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.00275	0.0257	CbGpPWpGaD
Furosemide—Epigastric discomfort—Hydrochlorothiazide—nephrolithiasis	0.00248	0.0305	CcSEcCtD
Furosemide—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.00229	0.0214	CbGpPWpGaD
Furosemide—SLC22A8—urine—nephrolithiasis	0.00228	0.0281	CbGeAlD
Furosemide—ALB—Scavenging of heme from plasma—AMBP—nephrolithiasis	0.00227	0.0212	CbGpPWpGaD
Furosemide—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.00193	0.0237	CcSEcCtD
Furosemide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A6—nephrolithiasis	0.00177	0.0166	CbGpPWpGaD
Furosemide—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.0017	0.0209	CcSEcCtD
Furosemide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A3—nephrolithiasis	0.00162	0.0152	CbGpPWpGaD
Furosemide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC3A1—nephrolithiasis	0.00162	0.0152	CbGpPWpGaD
Furosemide—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.00161	0.0198	CcSEcCtD
Furosemide—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.00148	0.0182	CcSEcCtD
Furosemide—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.00141	0.0173	CcSEcCtD
Furosemide—Gout—Hydrochlorothiazide—nephrolithiasis	0.0014	0.0171	CcSEcCtD
Furosemide—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.00134	0.0164	CcSEcCtD
Furosemide—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00133	0.0163	CcSEcCtD
Furosemide—CA7—renal system—nephrolithiasis	0.00128	0.0159	CbGeAlD
Furosemide—CA7—kidney—nephrolithiasis	0.00124	0.0153	CbGeAlD
Furosemide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A1—nephrolithiasis	0.00123	0.0115	CbGpPWpGaD
Furosemide—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00122	0.015	CcSEcCtD
Furosemide—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00118	0.0145	CcSEcCtD
Furosemide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A1—nephrolithiasis	0.00114	0.0107	CbGpPWpGaD
Furosemide—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00109	0.0134	CcSEcCtD
Furosemide—SLC22A11—nephron tubule—nephrolithiasis	0.00109	0.0134	CbGeAlD
Furosemide—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00108	0.0132	CcSEcCtD
Furosemide—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00108	0.0132	CcSEcCtD
Furosemide—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00107	0.0132	CcSEcCtD
Furosemide—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00106	0.013	CcSEcCtD
Furosemide—SLC12A1—nephron tubule—nephrolithiasis	0.00106	0.013	CbGeAlD
Furosemide—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00105	0.0129	CcSEcCtD
Furosemide—SLC22A6—nephron tubule—nephrolithiasis	0.00102	0.0126	CbGeAlD
Furosemide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A9—nephrolithiasis	0.00102	0.00953	CbGpPWpGaD
Furosemide—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.001	0.0123	CcSEcCtD
Furosemide—Thirst—Hydrochlorothiazide—nephrolithiasis	0.000995	0.0122	CcSEcCtD
Furosemide—SLC22A11—renal system—nephrolithiasis	0.000988	0.0122	CbGeAlD
Furosemide—Purpura—Hydrochlorothiazide—nephrolithiasis	0.000982	0.0121	CcSEcCtD
Furosemide—SLCO2A1—nephron tubule—nephrolithiasis	0.000975	0.012	CbGeAlD
Furosemide—SLC12A1—renal system—nephrolithiasis	0.00096	0.0119	CbGeAlD
Furosemide—SLC22A11—kidney—nephrolithiasis	0.000955	0.0118	CbGeAlD
Furosemide—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.000951	0.0117	CcSEcCtD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00095	0.00888	CbGpPWpGaD
Furosemide—SLC22A11—cortex of kidney—nephrolithiasis	0.00093	0.0115	CbGeAlD
Furosemide—SLC12A1—kidney—nephrolithiasis	0.000928	0.0115	CbGeAlD
Furosemide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—AMBP—nephrolithiasis	0.000905	0.00847	CbGpPWpGaD
Furosemide—SLC12A1—cortex of kidney—nephrolithiasis	0.000904	0.0112	CbGeAlD
Furosemide—PGD—NRF2 pathway—SLC2A9—nephrolithiasis	0.000888	0.00831	CbGpPWpGaD
Furosemide—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.000887	0.0109	CcSEcCtD
Furosemide—SLCO2A1—renal system—nephrolithiasis	0.000886	0.0109	CbGeAlD
Furosemide—SLC22A6—cortex of kidney—nephrolithiasis	0.000877	0.0108	CbGeAlD
Furosemide—PGD—nephron tubule—nephrolithiasis	0.000869	0.0107	CbGeAlD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.000869	0.00813	CbGpPWpGaD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.000869	0.00813	CbGpPWpGaD
Furosemide—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.000865	0.0106	CcSEcCtD
Furosemide—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.000862	0.0106	CcSEcCtD
Furosemide—SLCO2A1—kidney—nephrolithiasis	0.000857	0.0106	CbGeAlD
Furosemide—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.000853	0.0105	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.000853	0.0105	CcSEcCtD
Furosemide—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.000835	0.0103	CcSEcCtD
Furosemide—SLCO2A1—cortex of kidney—nephrolithiasis	0.000835	0.0103	CbGeAlD
Furosemide—CA12—renal system—nephrolithiasis	0.000834	0.0103	CbGeAlD
Furosemide—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.000824	0.0101	CcSEcCtD
Furosemide—CA12—kidney—nephrolithiasis	0.000807	0.00996	CbGeAlD
Furosemide—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.000802	0.00985	CcSEcCtD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000793	0.00742	CbGpPWpGaD
Furosemide—PGD—renal system—nephrolithiasis	0.00079	0.00975	CbGeAlD
Furosemide—PGD—kidney—nephrolithiasis	0.000764	0.00943	CbGeAlD
Furosemide—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.000756	0.00928	CcSEcCtD
Furosemide—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.000747	0.00917	CcSEcCtD
Furosemide—PGD—cortex of kidney—nephrolithiasis	0.000744	0.00918	CbGeAlD
Furosemide—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.000738	0.00906	CcSEcCtD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.000725	0.00678	CbGpPWpGaD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.000725	0.00678	CbGpPWpGaD
Furosemide—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.000723	0.00888	CcSEcCtD
Furosemide—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.000721	0.00675	CbGpPWpGaD
Furosemide—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.000717	0.00881	CcSEcCtD
Furosemide—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0007	0.00859	CcSEcCtD
Furosemide—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.000681	0.00836	CcSEcCtD
Furosemide—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.000671	0.00627	CbGpPWpGaD
Furosemide—CA1—renal system—nephrolithiasis	0.000661	0.00816	CbGeAlD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000658	0.00616	CbGpPWpGaD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000658	0.00616	CbGpPWpGaD
Furosemide—CA1—kidney—nephrolithiasis	0.000639	0.00789	CbGeAlD
Furosemide—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.000631	0.00775	CcSEcCtD
Furosemide—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.000619	0.0076	CcSEcCtD
Furosemide—SLC22A8—nephron tubule—nephrolithiasis	0.000613	0.00757	CbGeAlD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000612	0.00573	CbGpPWpGaD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000612	0.00573	CbGpPWpGaD
Furosemide—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.000611	0.0075	CcSEcCtD
Furosemide—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.000608	0.00569	CbGpPWpGaD
Furosemide—ABCC2—nephron tubule—nephrolithiasis	0.000598	0.00739	CbGeAlD
Furosemide—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.000585	0.00718	CcSEcCtD
Furosemide—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00057	0.007	CcSEcCtD
Furosemide—CA4—nephron tubule—nephrolithiasis	0.000568	0.00702	CbGeAlD
Furosemide—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.000566	0.00529	CbGpPWpGaD
Furosemide—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.000562	0.0069	CcSEcCtD
Furosemide—PGD—Carbohydrate metabolism—SLC26A1—nephrolithiasis	0.000562	0.00525	CbGpPWpGaD
Furosemide—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.000558	0.00685	CcSEcCtD
Furosemide—SLC22A8—renal system—nephrolithiasis	0.000558	0.00688	CbGeAlD
Furosemide—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00055	0.00515	CbGpPWpGaD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000549	0.00514	CbGpPWpGaD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000549	0.00514	CbGpPWpGaD
Furosemide—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.000548	0.00673	CcSEcCtD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000546	0.0051	CbGpPWpGaD
Furosemide—ABCC2—renal system—nephrolithiasis	0.000544	0.00672	CbGeAlD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000542	0.00507	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000542	0.00507	CbGpPWpGaD
Furosemide—SLC22A8—kidney—nephrolithiasis	0.000539	0.00665	CbGeAlD
Furosemide—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.000537	0.0066	CcSEcCtD
Furosemide—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.000527	0.00647	CcSEcCtD
Furosemide—ABCC2—kidney—nephrolithiasis	0.000526	0.00649	CbGeAlD
Furosemide—SLC22A8—cortex of kidney—nephrolithiasis	0.000525	0.00648	CbGeAlD
Furosemide—Agitation—Hydrochlorothiazide—nephrolithiasis	0.000524	0.00643	CcSEcCtD
Furosemide—CA4—renal system—nephrolithiasis	0.000517	0.00638	CbGeAlD
Furosemide—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.000512	0.00629	CcSEcCtD
Furosemide—ABCC2—cortex of kidney—nephrolithiasis	0.000512	0.00632	CbGeAlD
Furosemide—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.000512	0.00479	CbGpPWpGaD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000511	0.00478	CbGpPWpGaD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000511	0.00478	CbGpPWpGaD
Furosemide—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00051	0.00627	CcSEcCtD
Furosemide—CA4—kidney—nephrolithiasis	0.000499	0.00617	CbGeAlD
Furosemide—CA4—cortex of kidney—nephrolithiasis	0.000486	0.006	CbGeAlD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000483	0.00451	CbGpPWpGaD
Furosemide—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.000475	0.00583	CcSEcCtD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000473	0.00442	CbGpPWpGaD
Furosemide—CA2—nephron tubule—nephrolithiasis	0.000471	0.00582	CbGeAlD
Furosemide—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000469	0.00576	CcSEcCtD
Furosemide—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.000465	0.00571	CcSEcCtD
Furosemide—SLC22A5—nephron tubule—nephrolithiasis	0.000464	0.00572	CbGeAlD
Furosemide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.000459	0.0043	CbGpPWpGaD
Furosemide—Shock—Hydrochlorothiazide—nephrolithiasis	0.000458	0.00562	CcSEcCtD
Furosemide—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.000456	0.00559	CcSEcCtD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000455	0.00426	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000452	0.00423	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000452	0.00423	CbGpPWpGaD
Furosemide—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00045	0.00552	CcSEcCtD
Furosemide—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.000444	0.00545	CcSEcCtD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000441	0.00413	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000441	0.00413	CbGpPWpGaD
Furosemide—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000435	0.00534	CcSEcCtD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.000433	0.00405	CbGpPWpGaD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.000433	0.00405	CbGpPWpGaD
Furosemide—CA2—renal system—nephrolithiasis	0.000428	0.00529	CbGeAlD
Furosemide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.000427	0.00399	CbGpPWpGaD
Furosemide—SLC22A5—renal system—nephrolithiasis	0.000421	0.0052	CbGeAlD
Furosemide—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000418	0.00513	CcSEcCtD
Furosemide—CA2—kidney—nephrolithiasis	0.000414	0.00511	CbGeAlD
Furosemide—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000414	0.00508	CcSEcCtD
Furosemide—SLC22A5—kidney—nephrolithiasis	0.000407	0.00503	CbGeAlD
Furosemide—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000405	0.00497	CcSEcCtD
Furosemide—CA2—cortex of kidney—nephrolithiasis	0.000403	0.00498	CbGeAlD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000403	0.00377	CbGpPWpGaD
Furosemide—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000401	0.00493	CcSEcCtD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000399	0.00373	CbGpPWpGaD
Furosemide—Pain—Hydrochlorothiazide—nephrolithiasis	0.000398	0.00489	CcSEcCtD
Furosemide—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000398	0.00489	CcSEcCtD
Furosemide—SLC22A5—cortex of kidney—nephrolithiasis	0.000397	0.0049	CbGeAlD
Furosemide—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000383	0.00471	CcSEcCtD
Furosemide—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000381	0.00467	CcSEcCtD
Furosemide—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00037	0.00454	CcSEcCtD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000368	0.00345	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000368	0.00345	CbGpPWpGaD
Furosemide—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000368	0.00452	CcSEcCtD
Furosemide—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000368	0.00452	CcSEcCtD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.000365	0.00341	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.000365	0.00341	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000361	0.00337	CbGpPWpGaD
Furosemide—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.000343	0.00421	CcSEcCtD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000335	0.00313	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000335	0.00313	CbGpPWpGaD
Furosemide—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000334	0.0041	CcSEcCtD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00033	0.00309	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00033	0.00309	CbGpPWpGaD
Furosemide—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000329	0.00404	CcSEcCtD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000328	0.00307	CbGpPWpGaD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000328	0.00307	CbGpPWpGaD
Furosemide—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000318	0.00391	CcSEcCtD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000311	0.00291	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000311	0.00291	CbGpPWpGaD
Furosemide—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000308	0.00378	CcSEcCtD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000305	0.00285	CbGpPWpGaD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000305	0.00285	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000301	0.00282	CbGpPWpGaD
Furosemide—ABCC2—NRF2 pathway—SLC2A9—nephrolithiasis	0.000298	0.00279	CbGpPWpGaD
Furosemide—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000296	0.00363	CcSEcCtD
Furosemide—Rash—Hydrochlorothiazide—nephrolithiasis	0.000293	0.0036	CcSEcCtD
Furosemide—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000293	0.0036	CcSEcCtD
Furosemide—Headache—Hydrochlorothiazide—nephrolithiasis	0.000292	0.00358	CcSEcCtD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000279	0.00261	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000279	0.00261	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000277	0.00259	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000277	0.00259	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000276	0.00259	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000276	0.00259	CbGpPWpGaD
Furosemide—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000276	0.00339	CcSEcCtD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.000275	0.00258	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.000275	0.00258	CbGpPWpGaD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000272	0.00254	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00027	0.00252	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00027	0.00252	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00026	0.00243	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00026	0.00243	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000257	0.0024	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000257	0.0024	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00025	0.00234	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00025	0.00234	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00024	0.00225	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000232	0.00217	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000232	0.00217	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000231	0.00216	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000231	0.00216	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000229	0.00214	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000227	0.00213	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000227	0.00213	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000222	0.00207	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00022	0.00206	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00022	0.00206	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000209	0.00195	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000209	0.00195	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000207	0.00194	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000206	0.00192	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000206	0.00192	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000203	0.0019	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000194	0.00181	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000194	0.00181	CbGpPWpGaD
Furosemide—CA14—Metabolism—GRHPR—nephrolithiasis	0.000187	0.00175	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000185	0.00173	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000185	0.00173	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000185	0.00173	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000183	0.00171	CbGpPWpGaD
Furosemide—CA5A—Metabolism—GRHPR—nephrolithiasis	0.000182	0.0017	CbGpPWpGaD
Furosemide—CA6—Metabolism—GRHPR—nephrolithiasis	0.000182	0.0017	CbGpPWpGaD
Furosemide—PGD—Metabolism—GRHPR—nephrolithiasis	0.000176	0.00164	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000173	0.00162	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000172	0.00161	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000172	0.00161	CbGpPWpGaD
Furosemide—CA7—Metabolism—GRHPR—nephrolithiasis	0.00017	0.00159	CbGpPWpGaD
Furosemide—CA5B—Metabolism—GRHPR—nephrolithiasis	0.00017	0.00159	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000168	0.00157	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000168	0.00157	CbGpPWpGaD
Furosemide—CA14—Metabolism—AGXT—nephrolithiasis	0.000167	0.00156	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000167	0.00156	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000167	0.00156	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000166	0.00156	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000166	0.00156	CbGpPWpGaD
Furosemide—CA6—Metabolism—AGXT—nephrolithiasis	0.000162	0.00152	CbGpPWpGaD
Furosemide—CA5A—Metabolism—AGXT—nephrolithiasis	0.000162	0.00152	CbGpPWpGaD
Furosemide—PGD—Disease—SLC26A1—nephrolithiasis	0.000159	0.00149	CbGpPWpGaD
Furosemide—CA12—Metabolism—GRHPR—nephrolithiasis	0.000158	0.00147	CbGpPWpGaD
Furosemide—PGD—Metabolism—AGXT—nephrolithiasis	0.000157	0.00147	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000156	0.00146	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000155	0.00145	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000155	0.00145	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000153	0.00143	CbGpPWpGaD
Furosemide—CA7—Metabolism—AGXT—nephrolithiasis	0.000152	0.00142	CbGpPWpGaD
Furosemide—CA5B—Metabolism—AGXT—nephrolithiasis	0.000152	0.00142	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000148	0.00139	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.000143	0.00134	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.000143	0.00134	CbGpPWpGaD
Furosemide—PGD—Disease—ATP6V0A4—nephrolithiasis	0.000142	0.00133	CbGpPWpGaD
Furosemide—CA14—Metabolism—SLC26A1—nephrolithiasis	0.000142	0.00133	CbGpPWpGaD
Furosemide—CA14—Metabolism—APRT—nephrolithiasis	0.000142	0.00133	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00014	0.00131	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00014	0.00131	CbGpPWpGaD
Furosemide—CA12—Metabolism—AGXT—nephrolithiasis	0.00014	0.00131	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00014	0.00131	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00014	0.00131	CbGpPWpGaD
Furosemide—CA6—Metabolism—APRT—nephrolithiasis	0.000138	0.00129	CbGpPWpGaD
Furosemide—CA5A—Metabolism—APRT—nephrolithiasis	0.000138	0.00129	CbGpPWpGaD
Furosemide—CA6—Metabolism—SLC26A1—nephrolithiasis	0.000138	0.00129	CbGpPWpGaD
Furosemide—CA5A—Metabolism—SLC26A1—nephrolithiasis	0.000138	0.00129	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000138	0.00129	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000138	0.00129	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000136	0.00127	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000136	0.00127	CbGpPWpGaD
Furosemide—PGD—Metabolism—SLC26A1—nephrolithiasis	0.000133	0.00125	CbGpPWpGaD
Furosemide—PGD—Metabolism—APRT—nephrolithiasis	0.000133	0.00125	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000131	0.00122	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000131	0.00122	CbGpPWpGaD
Furosemide—CA5B—Metabolism—SLC26A1—nephrolithiasis	0.000129	0.00121	CbGpPWpGaD
Furosemide—CA5B—Metabolism—APRT—nephrolithiasis	0.000129	0.00121	CbGpPWpGaD
Furosemide—CA7—Metabolism—SLC26A1—nephrolithiasis	0.000129	0.00121	CbGpPWpGaD
Furosemide—CA7—Metabolism—APRT—nephrolithiasis	0.000129	0.00121	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000127	0.00119	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000127	0.00119	CbGpPWpGaD
Furosemide—CA4—Metabolism—GRHPR—nephrolithiasis	0.000126	0.00118	CbGpPWpGaD
Furosemide—CA2—Metabolism—GRHPR—nephrolithiasis	0.00012	0.00113	CbGpPWpGaD
Furosemide—CA12—Metabolism—APRT—nephrolithiasis	0.000119	0.00112	CbGpPWpGaD
Furosemide—CA12—Metabolism—SLC26A1—nephrolithiasis	0.000119	0.00112	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000118	0.0011	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000118	0.0011	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000116	0.00109	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000116	0.00109	CbGpPWpGaD
Furosemide—CA1—Metabolism—GRHPR—nephrolithiasis	0.000116	0.00108	CbGpPWpGaD
Furosemide—CA4—Metabolism—AGXT—nephrolithiasis	0.000112	0.00105	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00011	0.00103	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000108	0.00101	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000108	0.00101	CbGpPWpGaD
Furosemide—CA2—Metabolism—AGXT—nephrolithiasis	0.000107	0.001	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000106	0.000992	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000106	0.000992	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000105	0.000985	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000105	0.000985	CbGpPWpGaD
Furosemide—CA1—Metabolism—AGXT—nephrolithiasis	0.000103	0.000963	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000103	0.000961	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000103	0.000961	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.000102	0.000958	CbGpPWpGaD
Furosemide—CA9—Metabolism—GRHPR—nephrolithiasis	0.000102	0.00095	CbGpPWpGaD
Furosemide—CA14—Metabolism—AQP1—nephrolithiasis	0.000101	0.000945	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000101	0.000943	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000101	0.000943	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	9.86e-05	0.000922	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	9.86e-05	0.000922	CbGpPWpGaD
Furosemide—CA5A—Metabolism—AQP1—nephrolithiasis	9.84e-05	0.00092	CbGpPWpGaD
Furosemide—CA6—Metabolism—AQP1—nephrolithiasis	9.84e-05	0.00092	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	9.55e-05	0.000893	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	9.55e-05	0.000893	CbGpPWpGaD
Furosemide—CA4—Metabolism—SLC26A1—nephrolithiasis	9.52e-05	0.000891	CbGpPWpGaD
Furosemide—CA4—Metabolism—APRT—nephrolithiasis	9.52e-05	0.000891	CbGpPWpGaD
Furosemide—PGD—Metabolism—AQP1—nephrolithiasis	9.49e-05	0.000888	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—AQP1—nephrolithiasis	9.31e-05	0.000871	CbGpPWpGaD
Furosemide—CA7—Metabolism—AQP1—nephrolithiasis	9.19e-05	0.000859	CbGpPWpGaD
Furosemide—CA5B—Metabolism—AQP1—nephrolithiasis	9.19e-05	0.000859	CbGpPWpGaD
Furosemide—CA2—Metabolism—APRT—nephrolithiasis	9.13e-05	0.000854	CbGpPWpGaD
Furosemide—CA2—Metabolism—SLC26A1—nephrolithiasis	9.13e-05	0.000854	CbGpPWpGaD
Furosemide—CA14—Metabolism—CHRM3—nephrolithiasis	9.13e-05	0.000854	CbGpPWpGaD
Furosemide—CA9—Metabolism—AGXT—nephrolithiasis	9.05e-05	0.000847	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	8.99e-05	0.000841	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	8.92e-05	0.000835	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	8.92e-05	0.000835	CbGpPWpGaD
Furosemide—CA5A—Metabolism—CHRM3—nephrolithiasis	8.9e-05	0.000832	CbGpPWpGaD
Furosemide—CA6—Metabolism—CHRM3—nephrolithiasis	8.9e-05	0.000832	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	8.79e-05	0.000822	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	8.79e-05	0.000822	CbGpPWpGaD
Furosemide—CA1—Metabolism—SLC26A1—nephrolithiasis	8.75e-05	0.000819	CbGpPWpGaD
Furosemide—CA1—Metabolism—APRT—nephrolithiasis	8.75e-05	0.000819	CbGpPWpGaD
Furosemide—PGD—Metabolism—CHRM3—nephrolithiasis	8.59e-05	0.000803	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	8.51e-05	0.000796	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	8.51e-05	0.000796	CbGpPWpGaD
Furosemide—CA12—Metabolism—AQP1—nephrolithiasis	8.51e-05	0.000796	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—AQP1—nephrolithiasis	8.42e-05	0.000787	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CHRM3—nephrolithiasis	8.31e-05	0.000777	CbGpPWpGaD
Furosemide—CA7—Metabolism—CHRM3—nephrolithiasis	8.31e-05	0.000777	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	7.95e-05	0.000744	CbGpPWpGaD
Furosemide—CA9—Metabolism—SLC26A1—nephrolithiasis	7.7e-05	0.00072	CbGpPWpGaD
Furosemide—CA12—Metabolism—CHRM3—nephrolithiasis	7.7e-05	0.00072	CbGpPWpGaD
Furosemide—CA9—Metabolism—APRT—nephrolithiasis	7.7e-05	0.00072	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	7.27e-05	0.00068	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	7.27e-05	0.00068	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—AQP1—nephrolithiasis	7.02e-05	0.000657	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	6.8e-05	0.000637	CbGpPWpGaD
Furosemide—CA4—Metabolism—AQP1—nephrolithiasis	6.79e-05	0.000635	CbGpPWpGaD
Furosemide—CA2—Metabolism—AQP1—nephrolithiasis	6.51e-05	0.000609	CbGpPWpGaD
Furosemide—CA1—Metabolism—AQP1—nephrolithiasis	6.24e-05	0.000584	CbGpPWpGaD
Furosemide—CA4—Metabolism—CHRM3—nephrolithiasis	6.14e-05	0.000574	CbGpPWpGaD
Furosemide—CA2—Metabolism—CHRM3—nephrolithiasis	5.88e-05	0.00055	CbGpPWpGaD
Furosemide—CA1—Metabolism—CHRM3—nephrolithiasis	5.64e-05	0.000528	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	5.51e-05	0.000516	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	5.51e-05	0.000516	CbGpPWpGaD
Furosemide—CA9—Metabolism—AQP1—nephrolithiasis	5.48e-05	0.000513	CbGpPWpGaD
Furosemide—ALB—Hemostasis—DGKH—nephrolithiasis	5.28e-05	0.000494	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SLC7A9—nephrolithiasis	5.28e-05	0.000494	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	5.12e-05	0.000479	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	5.12e-05	0.000479	CbGpPWpGaD
Furosemide—CA9—Metabolism—CHRM3—nephrolithiasis	4.96e-05	0.000464	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	4.57e-05	0.000427	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	4.57e-05	0.000427	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—AQP1—nephrolithiasis	3.65e-05	0.000342	CbGpPWpGaD
Furosemide—ALB—Metabolism—GRHPR—nephrolithiasis	3.17e-05	0.000296	CbGpPWpGaD
Furosemide—ALB—Metabolism—AGXT—nephrolithiasis	2.82e-05	0.000264	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC26A1—nephrolithiasis	2.4e-05	0.000225	CbGpPWpGaD
Furosemide—ALB—Metabolism—APRT—nephrolithiasis	2.4e-05	0.000225	CbGpPWpGaD
Furosemide—ALB—Metabolism—AQP1—nephrolithiasis	1.71e-05	0.00016	CbGpPWpGaD
Furosemide—ALB—Metabolism—CHRM3—nephrolithiasis	1.55e-05	0.000145	CbGpPWpGaD
